Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
Nov 20, 2024 · Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online. ... November 21, 2024 News by Marisa Wexler, MS.
MRI analysis of MS ReBUILD data shows remyelination with...
Jun 16, 2023 · October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. March 6, 2024 News by Marisa Wexler, MS.
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · The Phase 2 FENopta trial (NCT05119569) evaluated fenebrutinib’s safety and efficacy in 109 adults, ages 18-55, with relapsing forms of MS, including relapsing-remitting MS and active secondary ...
Treatment of progressive MS hits milestones in recent years: Study
August 14, 2024 News by Esteban Domínguez Cerezo, MS. Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS. July 12, 2024 News by Katherine Poinsatte, PhD.
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
News; Top 10 MS stories of 2023 Top 10 MS stories of 2023. Of most interest to readers was news on potential treatments, triggers. by Marisa Wexler, MS | January 2, 2024.
MS prognosis and life expectancy - Multiple Sclerosis News Today
Feb 13, 2024 · MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy. ... Multiple Sclerosis News Today is strictly a news ...
The MS News Today Podcast - Multiple Sclerosis News Today
Jenn is the Brand and Marketing Manager for Bionews (Multiple Sclerosis News Today is a subsidiary of Bionews).Jenn is also the host of the Multiple Sclerosis Podcast as well as a featured ...
MS news notes: Vaccines, migraines, eye-tracking technology
Sep 18, 2023 · The MS News Today story “No greater risk of hospitalization found after vaccines in MS in study” reports on a nationwide study in France involving over 100,000 people, that “found no ...
About Us - Multiple Sclerosis News Today
Multiple Sclerosis News Today is a digital platform intended to provide the multiple sclerosis (MS) community with the most recent news and information on MS, as well as first-hand community ...
MS news notes: Vumerity, herpes virus, caregivers
Nov 27, 2023 · Final results are in from the EVOLVE-MS-1 clinical trial for patients with relapsing-remitting MS (RRMS) who were treated with Vumerity (diroximel fumarate), and the news is quite positive, as MS ...